GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zura Bio Ltd (STU:94E) » Definitions » EV-to-EBIT

Zura Bio (STU:94E) EV-to-EBIT : -5.42 (As of May. 31, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Zura Bio EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Zura Bio's Enterprise Value is €316.93 Mil. Zura Bio's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was €-58.48 Mil. Therefore, Zura Bio's EV-to-EBIT for today is -5.42.

The historical rank and industry rank for Zura Bio's EV-to-EBIT or its related term are showing as below:

STU:94E' s EV-to-EBIT Range Over the Past 10 Years
Min: -484.05   Med: 0   Max: 12.11
Current: -5.41

During the past 3 years, the highest EV-to-EBIT of Zura Bio was 12.11. The lowest was -484.05. And the median was 0.00.

STU:94E's EV-to-EBIT is ranked worse than
100% of 427 companies
in the Biotechnology industry
Industry Median: 9.72 vs STU:94E: -5.41

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Zura Bio's Enterprise Value for the quarter that ended in Mar. 2024 was €24.55 Mil. Zura Bio's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was €-58.48 Mil. Zura Bio's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -238.19%.


Zura Bio EV-to-EBIT Historical Data

The historical data trend for Zura Bio's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zura Bio EV-to-EBIT Chart

Zura Bio Annual Data
Trend Dec21 Mar22 Dec23
EV-to-EBIT
- - -1.98

Zura Bio Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only -38.05 -6.16 -3.92 -1.98 -0.56

Competitive Comparison of Zura Bio's EV-to-EBIT

For the Biotechnology subindustry, Zura Bio's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zura Bio's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zura Bio's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Zura Bio's EV-to-EBIT falls into.



Zura Bio EV-to-EBIT Calculation

Zura Bio's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=316.931/-58.476
=-5.42

Zura Bio's current Enterprise Value is €316.93 Mil.
Zura Bio's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-58.48 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zura Bio  (STU:94E) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Zura Bio's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 ) =EBIT / Enterprise Value (Q: Mar. 2024 )
=-58.476/24.550266
=-238.19 %

Zura Bio's Enterprise Value for the quarter that ended in Mar. 2024 was €24.55 Mil.
Zura Bio's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-58.48 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zura Bio EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Zura Bio's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Zura Bio (STU:94E) Business Description

Traded in Other Exchanges
Address
4225 Executive Square, Suite 600, La Jolla, CA, USA, 92037
Zura Bio Ltd is a multi-asset clinical-stage biotechnology company focused on developing novel medicines for immune and inflammatory disorders.

Zura Bio (STU:94E) Headlines

No Headlines